Increases in multidrug-resistance in the bacteria Streptococcus pneumoniae have made it the fourth-leading cause of death associated with antibiotic resistance. In a study in PLOS Biology, researchers ...
BOSTON--(BUSINESS WIRE)--Vaccine development company Matrivax announces the start of its Phase 1 clinical study to assess the safety, tolerability, and immunogenicity of its lead pneumococcal disease ...
In a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback